Oncternal Therapeutics, Inc. (ONCT)
NASDAQ: ONCT · IEX Real-Time Price · USD
8.60
0.00 (0.00%)
Apr 18, 2024, 12:00 AM EDT - Market open
Oncternal Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ONCT stock have an average target of 31.33, with a low estimate of 26 and a high estimate of 40. The average target predicts an increase of 264.30% from the current stock price of 8.60.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ONCT stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 3 | 3 | 3 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +225.58% | Apr 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $30 | Strong Buy | Maintains | $2 → $30 | +248.84% | Jan 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +365.12% | Dec 27, 2023 |
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $40 | Hold → Strong Buy | Upgrades | $40 | +365.12% | Dec 4, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $40 | Hold → Strong Buy | Upgrades | $40 | +365.12% | Sep 18, 2023 |
Financial Forecast
Revenue This Year
306.00K
from 785.00K
Decreased by -61.02%
Revenue Next Year
612.00K
from 306.00K
Increased by 100.00%
EPS This Year
-11.76
from -13.43
EPS Next Year
-10.46
from -11.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 630,000 | 630,000 | 787,500 | 787,500 |
| Avg | 306,000 | 612,000 | 765,000 | 765,000 |
| Low | n/a | 588,000 | 735,000 | 735,000 |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -19.7% | 105.9% | 28.7% | 2.9% |
| Avg | -61.0% | 100.0% | 25.0% | - |
| Low | - | 92.2% | 20.1% | -3.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -10.19 | -10.76 | -0.63 | -0.69 |
| Avg | -11.76 | -10.46 | -0.61 | -0.67 |
| Low | -13.08 | -10.05 | -0.59 | -0.65 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.